Nurami Medical
Nazareth, Israel· Est.
Nurami leverages electrospun nanofiber technology to deliver next‑generation dura‑repair implants that seal leaks and promote regeneration.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $30M
AI Company Overview
Nurami leverages electrospun nanofiber technology to deliver next‑generation dura‑repair implants that seal leaks and promote regeneration.
NeurosurgerySoft tissue repair
Technology Platform
Proprietary electrospun nanofiber scaffold combined with an ultra‑thin impermeable film, delivering a watertight, regenerative implant for soft‑tissue closure.
Opportunities
Expansion into additional surgical specialties and geographic markets, leveraging the modular nanofiber platform to develop new implant indications.
Risk Factors
Regulatory hurdles in new regions, competition from established dura‑repair devices, and the need to scale manufacturing while preserving quality standards.
Competitive Landscape
Nurami differentiates from collagen‑based patches and synthetic sutures by offering a combined scaffold‑film design that provides superior leak protection and regenerative support, but must contend with incumbents like Medtronic and Integra.